Avita Medical Net Income Over Time
| RCEL Stock | USD 4.16 0.44 11.83% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avita Medical Performance and Avita Medical Correlation. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. Anticipated expansion of Avita directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avita Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.81) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Investors evaluate Avita Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Avita Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Avita Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Avita Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Avita Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Avita Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare Avita Medical and related stocks such as InspireMD, Hyperfine, and Vivani Medical Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NSPR | (3.8 K) | (17.6 M) | (17.6 M) | (29.3 M) | (25.1 M) | (15.6 M) | (8.5 M) | (8.4 M) | (7.2 M) | (10 M) | (10.5 M) | (14.9 M) | (18.5 M) | (19.9 M) | (32 M) | (28.8 M) | (27.4 M) |
| HYPR | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (23.4 M) | (64.8 M) | (73.2 M) | (44.2 M) | (40.7 M) | (36.6 M) | (38.5 M) |
| VANI | (16.3 M) | (16.3 M) | (16.3 M) | (23 M) | (35.2 M) | (20 M) | (33.2 M) | (28.5 M) | (35.1 M) | (33.6 M) | (9.3 M) | (12.8 M) | (13.9 M) | (25.7 M) | (23.5 M) | (27 M) | (28.4 M) |
| QIPT | (34.1 K) | (548 K) | (2.5 M) | (1.4 M) | (18.3 M) | (57.4 M) | (19.2 M) | 14.5 M | (5.6 M) | (4.6 M) | (6.2 M) | 4.8 M | (2.8 M) | (6.8 M) | (10.7 M) | (9.6 M) | (9.1 M) |
| APYX | (154.1 K) | 109 K | 617 K | (4.3 M) | (17.3 M) | (5.4 M) | (4 M) | (5.1 M) | 64 M | (19.7 M) | (11.9 M) | (15.2 M) | (23.2 M) | (18.7 M) | (23.5 M) | (21.1 M) | (20.1 M) |
| XTNT | (15.8 K) | (3 M) | (7.7 M) | (12.7 M) | (10.5 M) | (2.2 M) | (19.5 M) | (52.4 M) | (70.1 M) | (8.2 M) | (7 M) | (4.8 M) | (8.5 M) | 660 K | (16.4 M) | (14.8 M) | (15.5 M) |
| OVID | (447 K) | (447 K) | (447 K) | (447 K) | (447 K) | (13.2 M) | (22.4 M) | (64.8 M) | (52 M) | (59.3 M) | (80.7 M) | 122.8 M | (51.4 M) | (52.3 M) | (26.4 M) | (23.8 M) | (25 M) |
| FONR | (7.5 M) | 5.8 M | 8.7 M | 10.4 M | 12.9 M | 15.7 M | 19.6 M | 21.2 M | 15.3 M | 8.2 M | 10.2 M | 12.4 M | 9.4 M | 10.6 M | 8.3 M | 9.6 M | 10.1 M |
| STTK | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (24 M) | (35.4 M) | (45 M) | (100.6 M) | (87.3 M) | (75.4 M) | (67.9 M) | (71.3 M) |
| LUCD | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (4.4 M) | (8.3 M) | (28.1 M) | (56.2 M) | (52.7 M) | (45.5 M) | (41 M) | (43 M) |
Avita Medical and related stocks such as InspireMD, Hyperfine, and Vivani Medical Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Avita Medical financial statement analysis. It represents the amount of money remaining after all of Avita Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Avita Medical | RCEL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 28159 Avenue Stanford, |
| Exchange | NASDAQ Exchange |
USD 4.16
Check out Avita Medical Performance and Avita Medical Correlation. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Avita Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.